Navigation Links
Cequent in Medical Technology

Cequent tkRNAi Technology to be Presented at the Centennial Meeting of the American Association for Cancer Research

...racts CAMBRIDGE, Mass., April 15 /PRNewswire/ -- cequent Pharmaceuticals, a pioneer in the development of n...cinoma, ovarian cancer, and others. About cequent Pharmaceuticals, Inc. ( www.cequentpharma.com ) An early-stage biopharmaceutical company, cequent is pioneering the development of novel therapeutic...

Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference

... CAMBRIDGE, Mass., Jan. 6 /PRNewswire/ -- cequent Pharmaceuticals, a pioneer in the development of n...ncer, and there is no medical treatment available. cequent will present its findings, the first-ever proof of... implicated in the progression of a disease," said cequent President and CEO, Peter Parker. "We have shown pr...

Cequent Pharmaceuticals' Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008

... CAMBRIDGE, Mass., April 30 /PRNewswire/ -- cequent Pharmaceuticals, a pioneer in the development of n...a non-human primate model -- an important step for cequent in the development of tkRNAi-based drugs for human...eline are based on this tkRNAi technology. About cequent Pharmaceuticals, Inc. An early-stage biopharmace...

Cequent Pharmaceuticals Founder to Present tkRNAi Technology at the American Association of Cancer Research Annual Meeting in Los Angeles

...s pipeline of clinical drug candidates. About cequent Pharmaceuticals, Inc. An early-stage biopharmaceutical company, cequent is pioneering the development of novel therapeutic...ly held company based in Cambridge, Massachusetts, cequent was established in 2006 with seed funding from Amp...
Cequent in Biological Technology

Two Luminaries Join Cequent Scientific Advisory Board: Judy Lieberman, M.D. Ph.D., and Patrice Courvalin, M.D.

Dr. Lieberman, of Harvard Medical School, is a prominent expert on RNAi delivery for therapeutic uses; Dr. Courvalin, of the Institut Pasteur, Paris, France, is foremost authority on bacterial genetic transfer CAMBRIDGE, Mass., Oct. 6 /PRNewswire/ -- Cequent Pharmaceuticals, a pioneer in ...

Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals' Board of Directors

CAMBRIDGE, Mass., May 5 /PRNewswire/ -- Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Michael D. Taylor, Ph.D., has joined the company's board of directors. Dr. Taylor is president and...

TriMas Corporation's Cequent Group Acquires Chem-Chrome, Inc.

TriMas Corporation, a growth company of diversified businesses, announced today that its Cequent Transportation Accessories Group has acquired Chem-Chrome, Inc., a provider of zinc plating services. Chem-Chrome is headquartered in Schofield, Wis. and has been a longtime processor for Cequent's Trai...

Cequent Names F. Stephen Laroux, Ph.D., Director, Immunology and Inflammatory Diseases

... CAMBRIDGE, Mass., June 2 /PRNewswire/ -- cequent Pharmaceuticals, a pioneer in the development of n...s a scientist in 2007. Today, he leads the team of cequent researchers developing drug candidates using Ceque... our rapid progress over the past 18 months," said cequent President and CEO, Peter Parker. "We started with ...

Cequent Names Ted Hibben Chief Business Officer

... CAMBRIDGE, Mass., Jan. 12 /PRNewswire/ -- cequent Pharmaceuticals, a pioneer in the development of n...any as chief business officer. Mr. Hibben comes to cequent from Coley Pharmaceutical Group, where he was most...velopment against multiple diseases. Ted brings to cequent a wealth of experience orchestrating a full range ...

Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo

... CAMBRIDGE, Mass., Sept. 15 /PRNewswire/ -- cequent Pharmaceuticals, a pioneer in the development of n... target the individual forms of the disease," said cequent President and CEO, Peter Parker. "When we started ...l further validate in in vivo animal trials before cequent selects the single target to be the subject of the...
Other Tags
(Date:8/30/2015)... (PRWEB) , ... August 30, 2015 , ... Lizzie’s ... a back to school special. The company is currently offering lice head checks for ... addition, the company is offering a 10% discount on their lice treatment products. “With ...
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional Products International ... the expansion of global cosmeceutical and skin care brands. Mr. Fernandez comes ... last 25 years working in operations, purchasing and management for some of the ...
(Date:8/29/2015)... ... August 30, 2015 , ... Electronic Informed Consent ... – 3:00 p.m. EDT, http://www.fdanews.com/electronicinformedconsent , The simple fact about electronic ... , Clinical trial sites can now use audio, video and interactivity ...
(Date:8/29/2015)... CA (PRWEB) , ... August 29, 2015 , ... Dr. ... a mission. His mission is to increase acceptance of the chiropractic field in ... medications that further debilitate them. Although Chiropractic was made available to the VA ...
(Date:8/29/2015)... ... August 29, 2015 , ... Hamstring strain ... stretching, soft tissue manipulation. Platelet rich plasma injections also have mixed results. ... improve treatment outcomes. This localized treatment seems to address the symptoms and ...
Breaking Medicine News(10 mins):Health News:Lizzie’s Lice Pickers Announces Back to School Head Check Special and Discounted Lice Treatment Products 2Health News:NPI Executive Vice President Leads Cosmeceutical Expansion 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 3Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 4Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3
(Date:8/3/2015)... SAN JOSE, Calif. , Aug. 3, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that members ... investment community at the Pacific Crest Global Technology Leadership ... Mountain Time. The conference will be held at the ... The presentation may include forward-looking information. ...
(Date:7/31/2015)... , Chine, 31 juillet 2015 La ... www.icg-10.org ) sera organisée par le BGI du ... Shenzhen en Chine. La ... son inauguration en 2006, l,ICG est devenue l,une ... le domaine des « omiques » et c,est aussi la ...
(Date:7/31/2015)... The 10 th International Conference on Genomics ... 22-25, 2015, in Shenzhen , ... 10 th anniversary this year. Since its inauguration in ... annual meetings in the ,omics, fields, and is one of ... ICG-10 focuses on recent breakthroughs and advances in ,omics, ...
Breaking Biology News(10 mins):La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3The 10th International Conference on Genomics (ICG-10) to Open in October 2
Other Contents